The human bcl-2 (B-cell lymphoma/leukaemia- 2) gene was identified at the breakpoint site of the t(14;18) chromosomal translocation that is associated with follicular lymphoma. In this translocation, bcl-2 moves from its normal location at 18q21 into juxtaposition with the lmmunogiobulin heavy-chain locus at 14(;132 (Ref. 1) , which results in its transcriptional activation and the overproduction of the 26 kDa Bcl-2 protein in iymphoma cells z,-~.
Bcl-2 is thought to contribute to oncogenesis by suppressing signals that induce apoptotic cell death. (For an introduction to apoptosis, see the box in the first article of this series In TCB, by McConkey and OrRnius.) For example, overexpresslon of bcl.2 can prevent haematopoletlc and neural cell apoptosis Induced by growth factor withdrawal *~, and bci.2 also prevents or delays apoptosls induced by ,/-Irradiation, glucocorticolds, heat shock and multiple chemotherapeutic drugs 74°.
The regulation of cell death by Bcl-2 has been conserved among divergent phyla. As discussed In the previous article on apoptosls by Osborne and Schwartz, the genes ced.3 and ced. 4 This article summarizes recent progress in characterizing gene products related to Bcl-2, examines the role of Bcl-2 in normal development and In oncogenesis, and then discusses the possible mechanisms of action of Bcl-2 in regulating apoptosis.
The growing family of/~r/.2.related genes bci-2 was the founding member of an expanding family of genes, which now includes bcl.x, bax, incl.1 and A1, that regulate apoptosis. The homology among the Bcl-2-related proteins is concentrated in two regions, termed BH1 and BH2 (Fig. 1) addition, proteins of the Bcl-2 family contain a stretch of hydrophobic amino acids at their C-termini, which appear important for attachment to Intracellular membranes !1,1z.
bci.x was recently isolated by hybridization to a bci-2 probe ~3 and by functional expression cloning (M. Gonz~lez-Garcia and G. Nuflez, unpublished). It gives rise to three transcripts by alternative splicing. The predicted Bcl-x L protein displays high-level homology to Bcl-2. As with bcl.2, transfection of bcix L into IL.3.dependent cells prevented their apoptotic cell death following growth factor deprivation ~3,~4. The predicted Bcl-x s protein lacks the internal re'glon'o~f 63 amino acids in BCI-x L that has greatest homology to Bcl-2. Surprisingly, transfection of bcl-x s failed to inhibit cell death; rather, it The incl.1 and A! genes were isolated by differen, tlal hybridization, incl.1 encodes a 37 kDa protein 16 and A1 encodes a 20 kDa protein 17, both of which display significant homology to Bcl-2 and Bci.x u par. tlcularly in the BH1 and BH2 domains (Pig. 1). rod. 1 and A I are early-response genes that are induced transiently by differentiation signals or growth factorsX6.*L mcl-1 appears to inhibit apoptosls (R, Craig and A. Eastman, pets. commun.), Overexpression of AI in IL-3-dependent cell lines delays their apoptotlc death induced by growth factor withdrawal (M, Benedict and G. Nufiez, unpublished).
Thus, the regulation of apoptosls in vertebrates by bcl.2 and related genes is complex and involves positive and negative functions. It is possible that further lx'l.2-related genes will be identified in the near future.
Bcl-2 function in v/vo
The expression of the bcl-2 gene is widespread in many fetal tissues 18, but in adult tissues bcl-2 appears to be expressed in cells that are rapidly dividing and differentiating into mature components (Table 1) . Such cells include stem ceils of the crypts of the gut epithelia or the skin, and early haematopoietic progenitors 19. bd-2 expression declines in cells as they mature, or at stages when cells may be eliminated. For example, bcl-2 is downregulated during keratinocyte or myeloid differentiation19; and transiently during B and T cell differentiation, at a stage when such cells are prone to undergo clonal elimination by apoptosis z°-2z. Taken together, these observations have led to the hypothesis that Bcl-2 is a survival favor for early progenitor cells and for fully differentiated cells that are long-lived. Conversely, downregulation of Bcl-2 during tissue differentiation appears to facilitate cell death that occurs during clonal selection or that is coupled to terminal differentiation of epithelial or haematopoietic tissues.
bcl-x mRNA is produced in a variety of tissues in the chicken, human and mouse 130~4. In the mouse, bcl-x L is the major bcl-x mRNA form expressed during embryonic and postnatal development, and in the adult it is highly expressed in the brain, kidney, bone marrow and thymus ~4. 
and oncogenesis
Malignant transformation can be thought of as arising from activation of the cell's mitogenic machinery and inactivation of the ~owth-inhibito W and apoptosis machinew, through multiple mutations, For example, in breast cancer, two of the most common abnormalities are deregulated expression of omyc and inactivation or mutation of the pS3 turnout suppressor gene a6. Expression of the gene encoding pS3 or certain oncogenes such as c-myc car induce s~me cancer cells to undergo apoptosisZT-~o which suggests that the cell death programme is a critical defence mechanism against malignant m In addition to a role in the genesis of cancers, the modulation of apoptosis may also influence the outcome of cancer treatment. Elegant studi,~s with p53 "knockout' mlc~ showed that X.lrradlatlon and certain chemotherapeutic agents kill cells through the pS3-dependent apoptosls pathway :~9,~°. In contrast, the expression of bcl.2 has been shown to protect cells from both chemotherapy and radiation-induced apoptosis 7,9,~o,13. Because Bd.2 production Is a common feature of many carcinomas, lymphomas and leukaemlas, it is thought that Bd-2 might play a role in the resistance to I therapy. Indeed, expression of bcl.2 in leukaemia, carcinoma of the prostate andneuroblastoma has been shown to be a marker for poor prognosis 41-44.
Cellular distribution of the Bcl.2 protein
Bcl-2 is a stable protein zl associated with organdies, especially mitochondrial membranes. It is now known to reside primarily in the outer mitochondrial membrane, nuclear envelope and endoplasmic reticulum (ER) ~s,46. Recent electron microscopy studies indicate that Bcl-x L has a subcellular distribution similar to that of Bcl-2 (Ref. 14) , which suggests that both proteins function in a sirnilar manner to prevent cell death (Fig. 2) . In vitro and in vivo studies showed that amino acids 187 to 216 of Bcl-2 are crucial for correct integration of its hydrophobic C-terminus into the membrane 11,]2. The N.terminus of the integrated protein is exposed to the cytosoPL Interestingly, during mitosis Bcl-2 may contact chromosomes 48, although the importance of this finding remains unknown.
The functional significance of Bcl-2 targeting to the outer membrane of cell organeiles is also unclear. Deletion of the hydrophobic C.termlnus of Bcl-2 abrogates much, but probably not all, of the
How does kl-2 prevent apoptosls?
The global changes in many cellular processes that occur during apoptosis make it difficult to distinguish cause from effect. Nevertheless, several roodels have been proposed to explain the inhibition of apoptosis by Bcl-2. Here we discuss clues to the function of Bcl-2 from knowledge of its cellular distribution, and then turn to possible mech. anisms of Bcl-2 action. Bcl.x L is granular and extranuclear, consistent with localization of Bcl-2 and Bcl-x L to cytoplasmic organelles. Dual labelling experiments and electron microscopy have shown that Bcl-2 and Bcl-x L localize primarily to the outer membrane of mitochondria, the ER and the nuclear envelope (see Table 1 for details and references). Model of apoptosis based on the interaction of Bcl-2 and Myc with pS3. In mouse erythroleukaemia cells, pS3 arrests cells in the G1 phase of the cell cycle, and induces apoptosis. [Arrest results from downregulation of c-my¢ expression, which Is obligate for cell cycle progression, and upregulation of Clpl expression (Clpl binds to cyclins and inhibits cell cycle progression).] The ability of pS3 to induce apoptods Is independent of Its cell cycle arrest function. Cells that coexpress pS3 and bd.2 are growth arrested, but apoptosis is delayed 3s. p$3 Is nuclear In these cells. We suggest that p53 activates an effector of apoptosls that Is Inhibited by Bcl-2. By contrast, cells that coexpress genes encoding p53, Bcl.2 and Myc continue to proliferate and do not undergo apoptosls 38. In such cells, p53 Is cytoplasmic during G1 when cells are susceptible to p$3-1nduced apoptosls and growth arrest 38. We postulate that Myc induces or activates a factor that cooperates with Bcl.2 to block p53 transport across the nuclear membrane, protective effects of the Bcl-2 protein u,~2, It is not clear whether the residual function of the mutant proteins results from interaction with cytoplasmic targets or integration of a small amount of the mutant protein into organelle membranes. Interestingly, Bcl-2 prevents the appearance of morphological changes characteristic of apoptosis in cells that do not contain mitochondrial DNA 49 or nuclei s0,
Bcl.2.interacting proteins
Recently, Bcl-2 has been shown to bind to two proteins: Bax and R-Ras. These observations have given insight into how Bcl.2 functions. As discussed above, increased levels of bax expression appear to counteract the effects of Bcl-2 and to promote, rather than inhibit, apoptosis ~s, Substitution of Gly145 of the BHI domain or Trp188 of the BH2 domain of Bcl-2 functionally inactivates the protein s~, and these mutants cannot bind Bax but can still form Bcl.2 homodimers s2. These results can be interpreted in three ways. First, it is possible that the Bcl-2 homodimer is normally the functional complex, but that the mutated homodimers are not fully active.
Second, the Bcl-2-Bax heterodimer may be the functional complex and the Bax-Bax homodimer may be a negative regulatorSL Third, the domains of Bcl-2 that interact with Bax might allow Bcl-2 to dimerize with another factor to form an active complex. In this latter case, neutralization of Bcl-2 by box overexpression may be explained by competition betwin Bax and the other Bcl-2 partner for B(~-2. The modulation of Bcl-2 activity by its partners may explain why Bcl-2 fails or is very poor in inhibiting some forms of apoptosis s.8.
The Bcl-2 protein also associates with the C-terminal 60 amino acids of the R-Ras protein, a 23 kDa membrane protein that is SS% homologous to HaRas sz. The Ras protein family consists of more than S0 proteins that regulate many diverse processes, such as cellular proliferation and differentiation, cytoskeletal control, and intracellular vesicular trafticking. Understanding of the consequences of the Bcl-2-R-Ras interaction awaits discovery of the function of the R-Ras protein.
Bcl-2 and oxygen free radical metabolism
As discussed in the article by McConkey and Orrenius, reactive oxygen species are thought to be involved in apoptosis. Recently, it has ~been postulated that Bcl-2 inhibits cell death by act-]t~g as an antioxidant s3 or inhibiting the generation of oxygen free radicals s4. In haematopoietic cells undergoing apoptosis after exposure to various apoptotic signals, overexpression of bd.2 was assoctatecl with decreased oxidative damage to cellular constituents, but was not associated with decreased formation of reactive oxygen Intermediates s3. However, in neuronal cells undergoing necrosis as a result of glutathlone depletion, expression of bcl.2 was associated with both decreased generation of oxygen free radicals and decreased oxidative damage to cellular constltuents s4. Thus, Bcl-2 appears to function as an antloxidant, However, it is unclear whether Bcl-2 protects against death specifically Induced by reactive oxygen species and, indeed, whether reactive oxygen intermediates are required for apoptosis.
Bcl.2 and intmceUular C~+
Bcl.2 may inhibit apoptosh by aitedng Ca z÷ fluxes through lntracellular organeJ]es. In some experimental systems, the release of Ca z~ tram a mobilizable pool located in the ER has been associated with apoptosis (see Orrenius and McConkey's article). Bcl-2 is located in ER membranes and its overpro. ductlon interfeRs with the efflux of Ca 2÷ across ER membranes in cells undergoing apoptosis ss,s6.
8cl-2 and modulation of subcellular tlafficking
The idea that Bcl-2 may play a role in nuclear ~lansport came from lmmunohistochemistry studies su88estln 8 that Bclo2 might be localized to nuclear pores 4s. Bcl-2 has recently been shown to alter the nucleocytoplasmic trafficking of p53 (Ref. 38 ) and the cdc2 and CD[C?. cell cycle regulatory proteins s7. Coexpression of bcl-2 with the gene encoding pS3 delayed pS3-induced apoptosis, but did not affect m p53 trafficking to the nucleus nor pS3-induced growth arrest; however, Bcl-2 and Myc cooperated to block p53 entry into the nucleus and thus prevented p53-induced apoptosis and growth arrest 3s. We speculate that Bcl-2 inhibits an effector of apoptosis that is activated by p53, and that Myc induces or activates afactor that cooperates with the membrane protein Bcl-2 to modulate the transport pathway responsible for the entry of p53 into the nucleus (see Fig. 3 ).
Future dlredions
Remarkable progress has been made in under° standing the role that Bclo2 and its family members play in regulating apoptosis and how this contributes to embryonic development, adult tissue homeostasis, and carcinogenesis. Apoptosis is characterized by changes in multiple cellular processes. It follows that Bcl-2 must block a single critical step that initiates these many events, or that it blocks all of the multiple events that together trigger apoptosis. A complete understanding of the factors with which Bcl-2 family members interact, and how these interactions regulate the mediators of apoptosis, will distinguish between these possibilities and lead to new insight into this unique cell viability regulatory system.
